Sen. William Delgado

Filed: 3/15/2013

 

 


 

 


 
09800SB1454sam001LRB098 09389 RLC 43135 a

1
AMENDMENT TO SENATE BILL 1454

2    AMENDMENT NO. ______. Amend Senate Bill 1454 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 316 as follows:
 
6    (720 ILCS 570/316)
7    Sec. 316. Prescription monitoring program.
8    The purpose of the Prescription Monitoring Program is to
9develop a clinical tool to assist healthcare providers in
10preventing accidental overdoses or duplications of controlled
11substances to the patients they are treating.
12    (a) The Department must provide for a prescription
13monitoring program for Schedule II, III, IV, and V controlled
14substances that includes the following components and
15requirements:
16        (1) The dispenser must transmit to the central

 

 

09800SB1454sam001- 2 -LRB098 09389 RLC 43135 a

1    repository, in a form and manner specified by the
2    Department, the following information:
3            (A) The recipient's name.
4            (B) The recipient's address.
5            (C) The national drug code number of the controlled
6        substance dispensed.
7            (D) The date the controlled substance is
8        dispensed.
9            (E) The quantity of the controlled substance
10        dispensed.
11            (F) The dispenser's United States Drug Enforcement
12        Administration registration number.
13            (G) The prescriber's United States Drug
14        Enforcement Administration registration number.
15            (H) The dates the controlled substance
16        prescription is filled.
17            (I) The payment type used to purchase the
18        controlled substance (i.e. Medicaid, cash, third party
19        insurance).
20            (J) The patient location code (i.e. home, nursing
21        home, outpatient, etc.) for the controlled substances
22        other than those filled at a retail pharmacy.
23            (K) Any additional information that may be
24        required by the department by administrative rule,
25        including but not limited to information required for
26        compliance with the criteria for electronic reporting

 

 

09800SB1454sam001- 3 -LRB098 09389 RLC 43135 a

1        of the American Society for Automation and Pharmacy or
2        its successor.
3        (2) The information required to be transmitted under
4    this Section must be transmitted not more than 7 days after
5    the date on which a controlled substance is dispensed, or
6    at such other time as may be required by the Department by
7    administrative rule.
8        (3) A dispenser must transmit the information required
9    under this Section by:
10            (A) an electronic device compatible with the
11        receiving device of the central repository;
12            (B) a computer diskette;
13            (C) a magnetic tape; or
14            (D) a pharmacy universal claim form or Pharmacy
15        Inventory Control form;
16        (4) The Department may impose a civil fine of up to
17    $100 per day for willful failure to report controlled
18    substance dispensing to the Prescription Monitoring
19    Program. The fine shall be calculated on no more than the
20    number of days from the time the report was required to be
21    made until the time the problem was resolved, and shall be
22    payable to the Prescription Monitoring Program.
23    (b) The Department, by rule, may include in the monitoring
24program certain other select drugs that are not included in
25Schedule II, III, IV, or V. The prescription monitoring program
26does not apply to controlled substance prescriptions as

 

 

09800SB1454sam001- 4 -LRB098 09389 RLC 43135 a

1exempted under Section 313.
2    (c) The collection of data on select drugs and scheduled
3substances by the Prescription Monitoring Program may be used
4as a tool for addressing oversight requirements of long-term
5care institutions as set forth by Public Act 96-1372. Long-term
6care pharmacies shall transmit patient medication profiles to
7the Prescription Monitoring Program monthly or more frequently
8as established by administrative rule.
9    (d) As a means of addressing potential pharmacotherapy
10needs under emergency conditions, the Prescription Monitoring
11Program shall be expanded to include every medication for each
12person within this State by January 1, 2015.
13    (e) By January 1, 2015, each electronic health record
14system must interface with the Prescription Monitoring System
15to ensure that each health care provider has access to specific
16patient records as he or she is treating the patient.
17(Source: P.A. 97-334, eff. 1-1-12.)".